Concepedia

Mrinal P. Dutia

MP

5

Publications

233

Citations

5

H-Index

2009

Active since

Affiliations

University of California Davis Medical Center(Current)

VA Northern California Health Care System

University of California, Davis

UC Davis Comprehensive Cancer Center

Mrinal P. Dutia is an author at University of California Davis Medical Center specializing in pharmacotherapy, oncology, and radiation oncology.

Top concepts

Publications per year

2009–2015

5

Publications

5

Phase I Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid Tumors

Benjamin Tomlinson, James A. Thomson, John S. Bomalaski et al. · Clinical Cancer Research · 2015 · 88 citations · Full text

Lenalidomide plus rituximab can produce durable clinical responses in patients with relapsed or refractory, indolent non‐<scp>H</scp>odgkin lymphoma

Joseph M. Tuscano, Mrinal P. Dutia, Karen Giselle Chee et al. · British Journal of Haematology · 2014 · 75 citations · Full text

Risk assessment models for cancer‐associated venous thromboembolism

Mrinal P. Dutia, Richard H. White, Ted Wun · Cancer · 2011 · 47 citations

Phase I study of the combination of temsirolimus and pazopanib in advanced solid tumors

Thomas J. Semrad, Courtney Eddings, Mrinal P. Dutia et al. · Anti-Cancer Drugs · 2013 · 12 citations

, , +14

R2: Preliminary Results of a Phase II Study of Lenalidomide and Rituximab in Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (NHL).

Mrinal P. Dutia, Ian DeRoock, Karen Giselle Chee et al. · Blood · 2009 · 11 citations

Rows per page

1–5 of 5